|
業務類別
|
Biotechnology |
|
業務概覽
|
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers. |
| 公司地址
| 1920 McKinney Avenue, 7th Floor, Dallas, TX, USA, 75201 |
| 電話號碼
| +1 972 277-1136 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.lanternpharma.com |
| 員工數量
| 16 |
| Mr. Panna L. Sharma |
Chief Executive Officer, President and Director |
美元 575.00K |
30/03/2026 |
| Mr. David R. Margrave |
Principal Accounting Officer, Chief Financial Officer and Secretary |
美元 413.80K |
30/03/2026 |
| Dr. Kishor G. Bhatia, PhD |
Chief Scientific Officer |
美元 316.00K |
08/08/2025 |
|
|
| Mr. Panna L. Sharma |
Chief Executive Officer, President and Director |
30/03/2026 |
| Dr. Vijay Chandru |
Independent Director |
30/03/2026 |
| Mr. Donald Jeffrey Keyser |
Chairman of the Board |
30/03/2026 |
| Mr. David S. Silberstein |
Independent Director |
30/03/2026 |
| Mr. Lee T. Schalop, M.D. |
Director |
30/03/2026 |
| Dr. Maria Maccecchini, PhD |
Independent Director |
30/03/2026 |
|
|
|
|
